Radial Access for Lower Extremity Peripheral Arterial Interventions: Do We Have the Tools?

Raghuram Posham; Lindsay B. Young; Robert A. Lookstein; Constantino Pena; Rahul S. Patel; Aaron M. Fischman

doi:10.1055/s-0038-1676341

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2018; 35(05): 427-434
DOI: 10.1055/s-0038-1676341

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Radial Access for Lower Extremity Peripheral Arterial Interventions: Do We Have the Tools?

Raghuram Posham

¹Icahn School of Medicine at Mount Sinai, New York, New York

,

Lindsay B. Young

¹Icahn School of Medicine at Mount Sinai, New York, New York

,

Robert A. Lookstein

¹Icahn School of Medicine at Mount Sinai, New York, New York

,

Constantino Pena

²Miami Cardiac and Vascular Institute, Miami, Florida

,

Rahul S. Patel

¹Icahn School of Medicine at Mount Sinai, New York, New York

,

Aaron M. Fischman

¹Icahn School of Medicine at Mount Sinai, New York, New York

› Author Affiliations

Abstract

The benefits of transradial arterial access (TRA) versus transfemoral arterial access (TFA) have been extensively described in the literature; however, TFA remains the predominant access site choice in the management of peripheral arterial disease (PAD). There are still significant unmet needs for operators wishing to provide the same effective interventions for lower extremity PAD via TRA as with TFA. This article provides an up-to-date review of the literature and devices currently available for operators wishing to treat lower extremity PAD via TRA and the limitations they may face.

Keywords

transradial access - peripheral arterial disease - interventional radiology - vascular intervention

Full Text

References

References
1 Sampson UK, Fowkes FG, McDermott MM. , et al. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart 2014; 9 (01) 145-158.e21
2 Curry SJ, Krist AH, Owens DK. , et al; US Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US preventive services task force recommendation statement. JAMA 2018; 320 (02) 177-183
3 Gerhard-Herman MD, Gornik HL, Barrett C. , et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135 (12) e686-e725
4 Romagnoli E, Biondi-Zoccai G, Sciahbasi A. , et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012; 60 (24) 2481-2489
5 Mehta SR, Jolly SS, Cairns J. , et al; RIVAL Investigators. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol 2012; 60 (24) 2490-2499
6 Valgimigli M, Gagnor A, Calabró P. , et al; MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 2015; 385 (9986): 2465-2476
7 Posham R, Biederman DM, Patel RS. , et al. Transradial approach for noncoronary interventions: a single-center review of safety and feasibility in the first 1,500 cases. J Vasc Interv Radiol 2016; 27 (02) 159-166
8 Le Corvoisier P, Gellen B, Lesault PF. , et al. Ambulatory transradial percutaneous coronary intervention: a safe, effective, and cost-saving strategy. Catheter Cardiovasc Interv 2013; 81 (01) 15-23
9 Amin AP, House JA, Safley DM. , et al. Costs of transradial percutaneous coronary intervention. JACC Cardiovasc Interv 2013; 6 (08) 827-834
10 Kok MM, Weernink MGM, von Birgelen C, Fens A, van der Heijden LC, van Til JA. Patient preference for radial versus femoral vascular access for elective coronary procedures: the PREVAS study. Catheter Cardiovasc Interv 2018; 91 (01) 17-24
11 Cooper CJ, El-Shiekh RA, Cohen DJ. , et al. Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison. Am Heart J 1999; 138 (3, Pt 1): 430-436
12 Titano JJ, Biederman DM, Zech J. , et al. Safety and outcomes of transradial access in patients with international normalized ratio 1.5 or above. J Vasc Interv Radiol 2018; 29 (03) 383-388
13 Baker NC, O'Connell EW, Htun WW. , et al. Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin. Am Heart J 2014; 168 (04) 537-544
14 Ratib K, Mamas MA, Anderson SG. , et al; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research. Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United kingdom. JACC Cardiovasc Interv 2015; 8 (1, Pt A) 20-29
15 Resnick NJ, Kim E, Patel RS, Lookstein RA, Nowakowski FS, Fischman AM. Uterine artery embolization using a transradial approach: initial experience and technique. J Vasc Interv Radiol 2014; 25 (03) 443-447
16 Bhatia S, Harward SH, Sinha VK, Narayanan G. Prostate artery embolization via transradial or transulnar versus transfemoral arterial access: technical results. J Vasc Interv Radiol 2017; 28 (06) 898-905
17 Staniloae CS, Korabathina R, Yu J, Kurian D, Coppola J. Safety and efficacy of transradial aortoiliac interventions. Catheter Cardiovasc Interv 2010; 75 (05) 659-662
18 Sanghvi K, Kurian D, Coppola J. Transradial intervention of iliac and superficial femoral artery disease is feasible. J Interv Cardiol 2008; 21 (05) 385-387
19 Cortese B, Peretti E, Troisi N, Siquilberti E, Setti M, Pitì A. Transradial percutaneous iliac intervention, a feasible alternative to the transfemoral route. Cardiovasc Revasc Med 2012; 13 (06) 331-334
20 Roy AK, Garot P, Louvard Y. , et al. Comparison of transradial vs transfemoral access for aortoiliac and femoropopliteal interventions: a single-center experience. J Endovasc Ther 2016; 23 (06) 880-888
21 Lorenzoni R, Mazzoni A, Lazzari M, Boni A, Gemignani C, Bovenzi F. Radial artery access for above the knee angioplasty: a feasibility study. EuroIntervention 2011; 7 (08) 924-929
22 Shinozaki N, Minowa T, Murakami T. , et al. Slender transradial iliac artery stenting using a 4.5 French guiding sheath. Cardiovasc Interv Ther 2018
23 Ruzsa Z, Tóth K, Nemes B. , et al. Transradial and transulnar access for iliac artery interventions using sheathless guiding systems: a feasibility study. Catheter Cardiovasc Interv 2016; 88 (06) 923-931
24 Mwipatayi BP, Sharma S, Daneshmand A. , et al; COBEST Co-Investigators. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg 2016; 64 (01) 83-94.e1
25 Hanna EB, Prout DL. Combined radial-pedal access strategy and radial-pedal rendezvous in the revascularization of complex total occlusions of the superficial femoral artery (the “no femoral access” strategy). J Endovasc Ther 2016; 23 (02) 321-329
26 Ruzsa Z, Bellavics R, Nemes B. , et al. Combined transradial and transpedal approach for femoral artery interventions. JACC Cardiovasc Interv 2018; 11 (11) 1062-1071
27 Armstrong EJ, Valle JA. Hand, foot, and word of mouth: combined transradial and transpedal access for femoral artery interventions. JACC Cardiovasc Interv 2018; 11 (11) 1072-1073
28 Hanna EB, Prout DL. Superficial femoral artery recanalization via transradial access or a combined radial-pedal access strategy. JACC Cardiovasc Interv 2018; 11 (17) 1786-1787
29 Kwan TW, Shah S, Amoroso N. , et al. Feasibility and safety of routine transpedal arterial access for treatment of peripheral artery disease. J Invasive Cardiol 2015; 27 (07) 327-330
30 Mustapha JA, Saab F, McGoff T. , et al. Tibio-pedal arterial minimally invasive retrograde revascularization in patients with advanced peripheral vascular disease: the TAMI technique, original case series. Catheter Cardiovasc Interv 2014; 83 (06) 987-994
31 Calsina Juscafresa L, Llort Pont C, Clará Velasco A. CUSUM analysis of brachial artery access for peripheral endovascular interventions. Int Angiol 2014; 33 (05) 441-445
32 Trani C, Tommasino A, Burzotta F. Pushing the limits forward: transradial superficial femoral artery stenting. Catheter Cardiovasc Interv 2010; 76 (07) 1065-1071
33 Trani C, Burzotta F, Tommasino A, Giammarinaro M. Transradial approach to treat superficial femoral artery in-stent restenosis. Catheter Cardiovasc Interv 2009; 74 (03) 494-498
34 Lorenzoni R, Lisi C, Corciu A, Lazzari M, Bovenzi F. Tailored use of transradial access for above-the-knee angioplasty. J Endovasc Ther 2014; 21 (05) 635-640
35 Dake MD, Ansel GM, Jaff MR. , et al; Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 2013; 61 (24) 2417-2427
36 Duda SH, Bosiers M, Lammer J. , et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16 (03) 331-338
37 Scheinert D, Duda S, Zeller T. , et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014; 7 (01) 10-19
38 Staniloae CS, Korabathina R, Coppola JT. Transradial access for peripheral vascular interventions. Catheter Cardiovasc Interv 2013; 81 (07) 1194-1203
39 Almasri J, Adusumalli J, Asi N. , et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg 2018; 68 (02) 624-633
40 Fischman AM, Swinburne NC, Patel RS. A technical guide describing the use of transradial access technique for endovascular interventions. Tech Vasc Interv Radiol 2015; 18 (02) 58-65
41 Treitl KM, König C, Reiser MF, Treitl M. Complications of transbrachial arterial access for peripheral endovascular interventions. J Endovasc Ther 2015; 22 (01) 63-70
42 Aminian A, Iglesias JF, Van Mieghem C. , et al. First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions. Catheter Cardiovasc Interv 2017; 89 (06) 1014-1020
43 Aminian A, Saito S, Takahashi A. , et al. Comparison of a new slender 6 Fr sheath with a standard 5 Fr sheath for transradial coronary angiography and intervention: RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT), a randomised multicentre trial. EuroIntervention 2017; 13 (05) e549-e556
44 Buturak A, Tekturk BM, Degirmencioglu A. , et al. Transradial catheterization may decrease the radial artery luminal diameter and impair the vasodilatation response in the access site at late term: an observational study. Heart Vessels 2016; 31 (04) 482-489
45 Shah RM, Patel D, Abbate A, Cowley MJ, Jovin IS. Comparison of transradial coronary procedures via right radial versus left radial artery approach: a meta-analysis. Catheter Cardiovasc Interv 2016; 88 (07) 1027-1033
46 Elmahdy MF, ElMaghawry M, Hassan M, Kassem HH, Said K, Elfaramawy AA. Comparison of safety and effectiveness between right versus left radial arterial access in primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction. Heart Lung Circ 2017; 26 (01) 35-40
47 Endovascular Today Device Guide: US Edition. 2018. Available at: https://evtoday.com/device-guide/ . Accessed October 1, 2018